Ikena Oncology Inc (NASDAQ: IKNA) is -32.32% lower on its value in year-to-date trading and has touched a low of $0.97 and a high of $1.94 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IKNA stock was last observed hovering at around $1.11 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $1.11, the stock is -7.77% and -15.81% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.14 million and changing 0.00% at the moment leaves the stock -29.52% off its SMA200. IKNA registered -12.60% loss for a year compared to 6-month loss of -35.09%. The firm has a 50-day simple moving average (SMA 50) of $1.3184 and a 200-day simple moving average (SMA200) of $1.574925.
The stock witnessed a -14.62% gain in the last 1 month and extending the period to 3 months gives it a -26.49%, and is 4.72% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.05% over the week and 7.56% over the month.
Ikena Oncology Inc (IKNA) has around 10 employees, a market worth around $44.69M and $0.00M in sales. Distance from 52-week low is 14.35% and -42.78% from its 52-week high. The company has generated returns on investments over the last 12 months (-37.97%).
The EPS is expected to grow by 24.18% this year
62.0 institutions hold shares in Ikena Oncology Inc (IKNA), with institutional investors hold 91.78% of the company’s shares. The shares outstanding are 48.26M, and float is at 13.81M with Short Float at 0.82%. Institutions hold 87.61% of the Float.
The top institutional shareholder in the company is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC with over 5.02 million shares valued at $8.28 million. The investor’s holdings represent 10.3986 of the IKNA Shares outstanding. As of 2024-06-30, the second largest holder is BVF INC/IL with 4.77 million shares valued at $7.87 million to account for 9.8826 of the shares outstanding. The other top investors are BLUE OWL CAPITAL HOLDINGS LP which holds 4.09 million shares representing 8.4776 and valued at over $6.75 million, while ORBIMED ADVISORS LLC holds 7.3342 of the shares totaling 3.54 million with a market value of $5.84 million.
